The CEO's sale is routine post-earnings option exercise and not a bearish signal given the strong fundamental backdrop. Monitor for any follow-on open-market sales by the CEO or other C-suite executives in the next 30 days. The raised guidance and 14th consecutive quarter of growth support the stock's current valuation. The cluster is neutral — no actionable trade signal.
Price Chart
Executive Summary
Twist Bioscience CEO Emily Leproust sold $14.2M in stock on Aug 10, 2026, following the company's strong Q3 earnings beat and raised guidance reported on Aug 3. The CEO's sale was part of a cashless exercise of 113,318 options at $26.66, with shares sold at $125.16 to cover taxes and realize gains. Director Robert Chess also sold $2.04M in a similar cashless exercise. Total insider selling of $18.14M represents 0.22% of the $8.2B market cap, which is modest in proportion. The cluster is dominated by option-exercise-related sales, not open-market liquidation of accumulated shares, reducing the bearish signal. The strong earnings beat and raised guidance provide a bullish fundamental backdrop that likely catalyzed these routine post-earnings sales.
Key Financial Metrics
Key Facts
- CEO Leproust sold 113,318 shares at $125.16 for $14.18M on Aug 10, 2026
- CEO's sale was part of a cashless exercise of options at $26.66 per share
- Director Chess sold 18,417 shares at $110.89 for $2.04M on Aug 7, 2026
- Total insider selling of $18.14M equals 0.22% of $8.2B market cap
- Company reported Q3 FY2026 revenue of $118.4M (+23% YoY, beat consensus) and raised FY2026 guidance to $456-457M on Aug 3, 2026
- Gross margin expanded to 52.8% (+120 bps sequentially), 14th consecutive quarter of sequential growth
Financial Impact
Insider selling of $18.14M (0.22% of market cap) is modest; option-exercise-related sales reduce bearish signal
Risk Factors
- CEO selling $14.2M could be perceived negatively by the market despite being option-exercise-related
- If additional open-market sales by C-suite emerge in coming weeks, sentiment could shift bearish
- Stock has rallied significantly (+23.57% on earnings day) — some profit-taking by insiders is natural
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-TWST-1786565153945 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 21d ago | Insider Cluster | $127.22 $166.99 | ▲ +31.26% | ▲ +31.60% | $187.45 (+47.34%) |
Aug 27, 2026 5w ago | Insider Cluster | $153.10 $128.71 | ▼ −15.93% | ▼ −16.20% | $187.45 (+22.44%) |
Aug 25, 2026 5w ago | Insider Cluster | $151.42 $132.06 | ▼ −12.79% | ▼ −12.25% | $187.45 (+23.79%) |
Aug 21, 2026 6w ago | Insider Cluster | $145.59 $141.38 | ▼ −2.89% | ▼ −3.37% | $187.45 (+28.75%) |
Aug 20, 2026 6w ago | Insider Cluster | $136.23 $153.10 | ▲ +12.38% | ▲ +11.27% | $187.45 (+37.60%) |
Aug 14, 2026 6w ago | Insider Cluster | $124.41 $140.80 | ▲ +13.17% | ▲ +14.36% | $187.45 (+50.67%) |
Aug 14, 2026 6w ago | Insider Cluster | $124.41 $140.80 | ▼ −13.17% | ▼ −14.36% | $187.45 (−50.67%) |
Aug 12, 2026 7w ago | Insider Cluster | $125.29 $136.23 | ▲ +8.73% | ▲ +10.70% | $187.45 (+49.61%) |
Aug 12, 2026 7w ago | 144 | $125.29 $136.23 | ▲ +8.73% | ▲ +10.70% | $187.45 (+49.61%) |
Aug 11, 2026 7w ago | Insider Cluster | $123.12 $116.10 | ▼ −5.70% | ▼ −5.30% | $187.45 (+52.25%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access